Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alex Gifford, MD, FCCP
Dartmouth-Hitchcock Medical Center
Principal Investigator - Nicole Mayer-Hamblett, PhD
University of Washington/Seattle Children's
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
80 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Tucson Cystic Fibrosis Center
Tucson, Arizona, United States
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Miller Children'S and Women'S Hospital Long Beach
Long Beach, California, United States
- Choc Children'S Hospital
Orange, California, United States
- Stanford University Medical Center
Palo Alto, California, United States
- Rady Children'S Hospital and Health Center at the University of California San Diego
San Diego, California, United States
- University of California, San Francisco - Adult Center
San Francisco, California, United States
- University of California, San Francisco - Peds Center
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- National Jewish Health
Denver, Colorado, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- University of Florida
Gainesville, Florida, United States
- Nemours Children'S Clinic
Jacksonville, Florida, United States
- Central Florida Pulmonary Group
Orlando, Florida, United States
- the Nemours Children'S Clinic - Orlando
Orlando, Florida, United States
- Nemours Children'S Clinic - Pensacola
Pensacola, Florida, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- Tampa General Hospital
Tampa, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Saint Luke'S Cystic Fibrosis Center of Idaho
Boise, Idaho, United States
- Northwestern University
Chicago, Illinois, United States
- Osf Saint Francis Medical Center
Peoria, Illinois, United States
- Riley Hospital for Children
Indianapolis, Indiana, United States
- University of Iowa
Iowa City, Iowa, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- University of Kentucky
Lexington, Kentucky, United States
- University of Louisville
Louisville, Kentucky, United States
- Tulane University
Metairie, Louisiana, United States
- Maine Medical Partners Pediatric Specialty Care
Portland, Maine, United States
- John Hopkins Hospital
Baltimore, Maryland, United States
- Boston Children'S Hospital, Brigham & Women'S Hospital
Boston, Massachusetts, United States
- University of Michigan, Michigan Medicine
Ann Arbor, Michigan, United States
- Wayne State University Harper University Hospital
Detroit, Michigan, United States
- Helen Devos Children'S Hospital
Grand Rapids, Michigan, United States
- Children'S Hospitals and Clinics of Minnesota
Minneapolis, Minnesota, United States
- the Minnesota Cystic Fibrosis Center
Minneapolis, Minnesota, United States
- Children'S Mercy Kansas City
Kansas City, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Aug 2020
- Primary completion
- 11 Jul 2022
- Completion
- 11 Jul 2022
- Last update posted
- 4 Dec 2024
- Registered enrollment
- 987
- Registry id
- NCT04378153
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.